Altium and these ASX 200 shares could be quality buy and hold options

I think Altium Limited (ASX:ALU) and these ASX 200 shares would be quality buy and hold options for ASX investors right now…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over the weekend I demonstrated how buy and hold investing can generate significant wealth for investors.

With that in mind, here are three shares which I think have the potential to be market beaters over the next decade, making them great buy and hold options today:

Altium Limited (ASX: ALU)

I think Altium is one of the best buy and hold options on the ASX. This is because of the strong growth potential of its printed circuit board (PCB) design software platform, Altium Designer. This platform has exposure to the fast-growing Internet of Things (IoT) market. As almost all IoT devices have PCBs inside them, I feel this bodes well for subscriber numbers in the future. Management certainly believes this will be the case. It is aiming to grow its revenue to US$500 million by FY 2025. This compares to Altium FY 2019's revenue of US$171.8 million.

CSL Limited (ASX: CSL)

I think that this global biotherapeutics company could arguably be the best buy and hold option on the Australian share market. Over the last 10 years the CSL share price has provided investors with an average total return of approximately 24.45% per annum. Pleasingly, I believe that its shares could continue to provide outsized returns for shareholders over the next decade. This is thanks to the quality of its products, management team, and lucrative research and development pipeline.

ResMed Inc (ASX: RMD)

A final buy and hold option to consider is ResMed. It is a leading developer of products that treat sleep apnoea, chronic obstructive pulmonary disease, and other chronic respiratory diseases. According to management, approximately 1 billion people are estimated to be impacted by sleep apnoea worldwide. The vast majority of these people are undiagnosed and at risk of life-threatening conditions such as chronic daytime fatigue, heart disease, stroke, type 2 diabetes, and depression. With education around the condition increasing, I expect more and more people to be diagnosed over the next decade. This is likely to lead to increasing demand for its industry-leading products and services.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Altium and CSL Ltd. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ ASX Shares

a woman wearing a close-sitting hat featuring wires and thick computer screen glasses clutches her computer monitor and looks shocked and disturbed as she reads old-fashioned computer text from the screen.
Technology Shares

Here's why ASX 200 tech shares (ASX:XTX) outperformed today

ASX tech shares have taken a turn for the better today.

Read more »

Worker in hard hat looks puzzled with one hand on chin
Resources Shares

Why did the Rio Tinto share price (ASX:RIO) have such a lousy 2021?

We look at what happened to this ASX 200 mining giant's shares last year

Read more »

a miner wearing a hard hat smiles as he stands in front of heavy earth moving equipment on a barren mine site.
Share Gainers

Here's why the Rumble Resources (ASX:RTR) share price is climbing 5%

The mineral explorer's share price is on the rise amid promising drill results.

Read more »

share price high, all time record, record share price, highest, price rise, increase, up,
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Wednesday

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

comical investor reading documents and surrounded by calculators
⏸️ ASX Shares

The ASX reporting wrap-up: WiseTech, Bravura, Seven Group

Just what the investor ordered. Here’s a recap of the companies that reported on Wednesday...

Read more »

Doctor performing an ultrasound on pregnant woman
⏸️ ASX Shares

The ASX reporting wrap-up: Ansell, Kogan, Nanosonics

Just what the investor ordered. Here’s a recap of the companies that reported on Tuesday...

Read more »

blue arrows representing a rising share price ASX 200
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Tuesday

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »

unhappy investor considering computer screen
Share Market News

The ASX reporting wrap-up: Charter Hall, Ampol, NIB Holdings

Just what the investor ordered. Here’s a recap of the companies that reported on Monday...

Read more »